Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi

A retrospective database review showed that Haemophilus influenzae type b conjugate vaccine decreased the annual number of cases of H. influenzae type b meningitis in children in Blantyre, Malawi. Among young bacterial meningitis patients, HIV prevalence was high (36.7% during 1997–2009), and pneumo...

Descripción completa

Detalles Bibliográficos
Autores principales: McCormick, David W., Molyneux, Elizabeth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2011
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377403/
https://www.ncbi.nlm.nih.gov/pubmed/21470461
http://dx.doi.org/10.3201/eid1704.101045
_version_ 1782235950230798336
author McCormick, David W.
Molyneux, Elizabeth M.
author_facet McCormick, David W.
Molyneux, Elizabeth M.
author_sort McCormick, David W.
collection PubMed
description A retrospective database review showed that Haemophilus influenzae type b conjugate vaccine decreased the annual number of cases of H. influenzae type b meningitis in children in Blantyre, Malawi. Among young bacterial meningitis patients, HIV prevalence was high (36.7% during 1997–2009), and pneumococcus was the most common etiologic agent (57% in 2009).
format Online
Article
Text
id pubmed-3377403
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-33774032012-06-20 Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi McCormick, David W. Molyneux, Elizabeth M. Emerg Infect Dis Dispatch A retrospective database review showed that Haemophilus influenzae type b conjugate vaccine decreased the annual number of cases of H. influenzae type b meningitis in children in Blantyre, Malawi. Among young bacterial meningitis patients, HIV prevalence was high (36.7% during 1997–2009), and pneumococcus was the most common etiologic agent (57% in 2009). Centers for Disease Control and Prevention 2011-04 /pmc/articles/PMC3377403/ /pubmed/21470461 http://dx.doi.org/10.3201/eid1704.101045 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
McCormick, David W.
Molyneux, Elizabeth M.
Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
title Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
title_full Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
title_fullStr Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
title_full_unstemmed Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
title_short Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
title_sort bacterial meningitis and haemophilus influenzae type b conjugate vaccine, malawi
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377403/
https://www.ncbi.nlm.nih.gov/pubmed/21470461
http://dx.doi.org/10.3201/eid1704.101045
work_keys_str_mv AT mccormickdavidw bacterialmeningitisandhaemophilusinfluenzaetypebconjugatevaccinemalawi
AT molyneuxelizabethm bacterialmeningitisandhaemophilusinfluenzaetypebconjugatevaccinemalawi

Ejemplares similares